Staphylococcus aureus type 8 capsular saccharides
AssigneeGlaxosmithkline Biologicals SA
InventorsPaolo COSTANTINO, Maria Rosaria ROMANO, Francesco BERTI
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlaxosmithkline Biologicals SA
InventorsPaolo COSTANTINO, Maria Rosaria ROMANO, Francesco BERTI
Estimating the term…
The invention provides a method for releasing capsular polysaccharide from S. aureus type 5 or type 8 cells, comprising the step of treating the cells with acid. The invention further provides a process for purifying capsular polysaccharide from S. aureus type 5 or type 8 cells comprising this method. Other processing steps may be included in the process, such as enzymatic treatment, e.g. to remove nucleic acid, protein and/or peptidoglycan contaminants; diafiltration, e.g. to remove low molecular weight contaminants; anion exchange chromatography, e.g. to remove residual protein; and concentration.
1-26. (canceled)
A composition comprising an S. aureus type 8 capsular polysaccharide obtainable by a process comprising the step of treating the cells with acid, wherein the acid treatment results in the capsular polysaccharide having a degree of O-acetylation between 60-100%.
Dependencies are inferred from the claim text.